IPO GMP race: Reliance Jio Platforms IPO vs Paras Healthcare IPO - Check grey market winner
Jio Platforms’ IPO attracted strong Day 1 demand, with subscription reported at 3.04 times and a grey market premium suggesting potential listing gains of about 22%. Paras Healthcare’s muted 0.15-times subscription and ₹30 premium indicated estimated gains of roughly 4.33%.
Mukesh Ambani’s Reliance Industries Limited (RIL)-backed Jio Platforms’s IPO GMP stood at ₹ 249. Considering its grey market premium and upper price band, the Jio IPO is likely to be listed at ₹ 1368 per share (which is the sum of IPO GMP and upper price band), which hints at 22.25% of expected listing gain.
Paras Healthcare IPO grey market premium (GMP) was recorded at ₹ 30, as per media reports at 8 pm on October 21. With an upper price band of ₹ 693, the estimated listing price for Paras Healthcare IPO is ₹ 723 (which is the sum of upper price band and latest grey market premium). The IPO is expected to be listed with 4.33% gain.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.
